Governmental funding and policy reforms are acting as major catalysts for the expansion of treatment infrastructure across the globe. According to the latest Opioid Use Disorder Market forecast, the sector is expected to maintain a steady compound annual growth rate as more nations decriminalize addiction and prioritize public health over punitive measures. This shift is particularly evident in North America, where emergency grants are being funneled into community-based recovery centers.

The upcoming decade will likely see a surge in the approval of long-acting injectable formulations that simplify dosing schedules. By reducing the burden of daily medication adherence, these innovative delivery systems offer a more discreet and manageable path to recovery. Consequently, pharmaceutical companies are increasingly focusing their R&D efforts on extended-release technologies to meet the growing clinical demand.